Promea Revolutionizes Healthcare with Dr. Protech H+ Hemoglobin Analyzer

Global Market Welcomes Groundbreaking Product of “MAKE IN TELANGANA” dedicated towards “Anemia Mukt Bharat

Hyderabad (Telangana) [India], October 23:  In a remarkable leap forward in the realm of healthcare, Promea Therapeutics proudly introduces the global availability of the Dr. Protech H+ Hemoglobin Analyzer, a pioneering device that promises to redefine point-of-care haemoglobin testing.

Promea Therapeutics is a leading startup in Telangana, India that is committed to Make in Telangana and Make in India. The company develops and manufactures innovative medical devices with a focus on improving healthcare delivery in India and around the world.

Promea’s flagship product is the Dr. Protech H+ Hemoglobin Analyzer, a portable, battery-operated device that uses reagent-based micro cuvettes to deliver accurate and reliable hemoglobin results in less than 5 seconds. It is the first Indian-made hemoglobin analyzer with reagent-based micro cuvettes, and one of only two point-of-care hemoglobin devices in the world that can deliver results in less than 5 seconds. The Dr. Protech H+ Hemoglobin Analyzer is an ideal solution for a variety of settings, including hospitals, clinics, rural health centers, and blood donation camps. It is easy to use, affordable, and requires only a small sample of blood.

Promea is also developing a wide range of other In-Vitro Diagnostic medical devices, including electrolyte analyzers, blood gas analyzers, clinical chemistry analyzers, blood glucose meters, hematology analyzers etc. The company is committed to using cutting-edge technology to develop innovative products that address the unmet needs of patients and healthcare professionals.

Promea’s commitment to Make in Telangana and Make in India is evident in its state-of-the-art manufacturing facility located in Medical Devices Park, Hyderabad, Telangana. The facility is equipped with the latest technology and machinery, and employs a highly skilled workforce.

Promea’s success is a testament to the potential of Telangana as a hub for medical device manufacturing. The state government is committed to supporting the growth of the medical device industry, and has created a conducive environment for businesses like Promea to thrive. Promea has been an inspiration to other startups in Telangana and India. The company’s success shows that it is possible to develop and manufacture innovative medical devices in India. Promea’s commitment to Make in Telangana and Make in India is helping to make healthcare more accessible and affordable for everyone.

In an exclusive interview, Mr. Pavan Chandra Nagoor, the Commercial Director at Promea Therapeutics, sheds light on this groundbreaking innovation.

Can you tell us more about the Dr. Protech H+ Hemoglobin Analyzer and its significance?

The Dr. Protech H+ Hemoglobin Analyzer is a cutting-edge device that offers rapid and precise hemoglobin analysis, delivering results in less than 5 seconds. What sets it apart is its reagent-based micro cuvettes, ensuring unmatched accuracy and reliability in point-of-care hemoglobin testing.

What motivated Promea to develop this revolutionary product?

Our motivation was rooted in addressing the critical health issue of anemia, which remains a widespread concern in India and many parts of the world. We wanted to empower healthcare professionals with a valuable tool for the efficient diagnosis and management of anaemia.

Could you explain the significance of “Anemia Mukt Bharat” in this context?

“Anemia Mukt Bharat” translates to “Anemia-Free India.” It’s a crucial mission aimed at combating anemia and enhancing the health and well-being of millions of Indians. By dedicating the Dr. Protech H+ Hemoglobin Analyzer to this mission, we are actively contributing to this important goal.

What distinguishes the Dr. Protech H+ Hemoglobin Analyzer from other devices in the market?

One of its key differentiators is its exceptional speed, providing results in less than 5 seconds, which is a significant advantage for healthcare professionals and patients. The reagent-based cuvettes ensure the accuracy and reliability of results, making it an invaluable tool in point-of-care hemoglobin testing.

Can you share more about the global availability of the Dr. Protech H+ Hemoglobin Analyzer?

We are thrilled to introduce this technology to the global market. We believe that healthcare professionals worldwide will benefit from the speed and precision of our device. Our commitment is to make this state-of-the-art solution easily accessible to clinics, diagnostic centers, and healthcare facilities around the world.

What message would you like to convey to the world as the Dr. Protech H+ Analyzer becomes available globally?

We want the world to know that innovation in healthcare can originate from anywhere, and Promea is dedicated to being at the forefront of this innovation. The Dr. Protech H+ Hemoglobin Analyzer is more than just a device; it represents our commitment to improving healthcare, eliminating anemia, and making the world a healthier place for all.

This landmark achievement is a testament to Promea’s dedication to healthcare innovation and its promise to contribute to “Anemia Mukt Bharat.” As the world embraces this groundbreaking technology, Promea takes a giant step forward in revolutionizing healthcare for everyone.

With a focus on improving healthcare delivery, Promea aims to create a healthier and happier world for all. For more information, please visit

If you have any objection to this press release content, kindly contact pr.error.rectification[at] to notify us. We will respond and rectify the situation in the next 24 hours.

Previous post SRK’s New Dance TVC with Denver is Viral
Next post Is Print Media Advertising Still Effective for Startups, or Is It a Thing of the Past?